1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. CLINICAL RESEARCH ORGANIZATION MARKET BY SERVICE TYPE
5.1. Introduction
5.2. Early phase development services
5.2.1. Market Trends and Opportunities
5.2.2. Growth Prospects
5.2.3. Discovery services
5.2.4. Chemistry, manufacturing & control (CMC)
5.2.5. Preclinical services
5.2.5.1. Pharmacokinetics/Pharmacodynamics (PK/PD)
5.2.5.2. Toxicology services
5.2.5.3. Others
5.3. Clinical research services
5.3.1. Market Trends and Opportunities
5.3.2. Growth Prospects
5.3.3. Phase I
5.3.4. Phase II
5.3.5. Phase III
5.3.6. Phase IV
5.4. Laboratory services
5.4.1. Market Trends and Opportunities
5.4.2. Growth Prospects
5.4.3. Bioanalytical testing services
5.4.4. Analytical testing services
5.4.5. Physical Characterization
5.4.6. Raw Material Testing
5.4.7. Batch Release Testing
5.4.8. Stability Testing
5.4.9. Others
5.5. Regulatory consulting services
5.5.1. Market Trends and Opportunities
5.5.2. Growth Prospects
6. CLINICAL RESEARCH ORGANIZATION MARKET BY THERAPEUTIC AREA
6.1. Introduction
6.2. Oncology
6.2.1. Market Trends and Opportunities
6.2.2. Growth Prospects
6.3. Clinical pharmacology
6.3.1. Market Trends and Opportunities
6.3.2. Growth Prospects
6.4. Cardiology
6.4.1. Market Trends and Opportunities
6.4.2. Growth Prospects
6.5. Infectious disease
6.5.1. Market Trends and Opportunities
6.5.2. Growth Prospects
6.6. Neurology
6.6.1. Market Trends and Opportunities
6.6.2. Growth Prospects
6.7. Gastroenterology & Hepatology
6.7.1. Market Trends and Opportunities
6.7.2. Growth Prospects
6.8. Ophthalmology
6.8.1. Market Trends and Opportunities
6.8.2. Growth Prospects
6.9. Others
6.9.1. Market Trends and Opportunities
6.9.2. Growth Prospects
7. CLINICAL RESEARCH ORGANIZATION MARKET BY END-USER
7.1. Introduction
7.2. Pharmaceutical & Biopharmaceutical Companies
7.2.1. Market Trends and Opportunities
7.2.2. Growth Prospects
7.3. Medical Device Companies
7.3.1. Market Trends and Opportunities
7.3.2. Growth Prospects
7.4. Academic Institutes
7.4.1. Market Trends and Opportunities
7.4.2. Growth Prospects
8. CLINICAL RESEARCH ORGANIZATION MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Service Type
8.2.2. By Therapeutic Area
8.2.3. By End User
8.2.4. By Country
8.2.4.1. United States
8.2.4.1.1. Market Trends and Opportunities
8.2.4.1.2. Growth Prospects
8.2.4.2. Canada
8.2.4.2.1. Market Trends and Opportunities
8.2.4.2.2. Growth Prospects
8.2.4.3. Mexico
8.2.4.3.1. Market Trends and Opportunities
8.2.4.3.2. Growth Prospects
8.3. South America
8.3.1. By Service Type
8.3.2. By Therapeutic Area
8.3.3. By End User
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.1.1. Market Trends and Opportunities
8.3.4.1.2. Growth Prospects
8.3.4.2. Argentina
8.3.4.2.1. Market Trends and Opportunities
8.3.4.2.2. Growth Prospects
8.3.4.3. Others
8.3.4.3.1. Market Trends and Opportunities
8.3.4.3.2. Growth Prospects
8.4. Europe
8.4.1. By Service Type
8.4.2. By Therapeutic Area
8.4.3. By End User
8.4.4. By Country
8.4.4.1. United Kingdom
8.4.4.1.1. Market Trends and Opportunities
8.4.4.1.2. Growth Prospects
8.4.4.2. Germany
8.4.4.2.1. Market Trends and Opportunities
8.4.4.2.2. Growth Prospects
8.4.4.3. France
8.4.4.3.1. Market Trends and Opportunities
8.4.4.3.2. Growth Prospects
8.4.4.4. Italy
8.4.4.4.1. Market Trends and Opportunities
8.4.4.4.2. Growth Prospects
8.4.4.5. Spain
8.4.4.5.1. Market Trends and Opportunities
8.4.4.5.2. Growth Prospects
8.4.4.6. Others
8.4.4.6.1. Market Trends and Opportunities
8.4.4.6.2. Growth Prospects
8.5. Middle East and Africa
8.5.1. By Service Type
8.5.2. By Therapeutic Area
8.5.3. By End User
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.1.1. Market Trends and Opportunities
8.5.4.1.2. Growth Prospects
8.5.4.2. UAE
8.5.4.2.1. Market Trends and Opportunities
8.5.4.2.2. Growth Prospects
8.5.4.3. Others
8.5.4.3.1. Market Trends and Opportunities
8.5.4.3.2. Growth Prospects
8.6. Asia Pacific
8.6.1. By Service Type
8.6.2. By Therapeutic Area
8.6.3. By End User
8.6.4. By Country
8.6.4.1. Japan
8.6.4.1.1. Market Trends and Opportunities
8.6.4.1.2. Growth Prospects
8.6.4.2. China
8.6.4.2.1. Market Trends and Opportunities
8.6.4.2.2. Growth Prospects
8.6.4.3. India
8.6.4.3.1. Market Trends and Opportunities
8.6.4.3.2. Growth Prospects
8.6.4.4. South Korea
8.6.4.4.1. Market Trends and Opportunities
8.6.4.4.2. Growth Prospects
8.6.4.5. Taiwan
8.6.4.5.1. Market Trends and Opportunities
8.6.4.5.2. Growth Prospects
8.6.4.6. Thailand
8.6.4.6.1. Market Trends and Opportunities
8.6.4.6.2. Growth Prospects
8.6.4.7. Indonesia
8.6.4.7.1. Market Trends and Opportunities
8.6.4.7.2. Growth Prospects
8.6.4.8. Others
8.6.4.8.1. Market Trends and Opportunities
8.6.4.8.2. Growth Prospects
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Charles River Laboratories, Inc.
10.2. Laboratory Corporation of America Holdings
10.3. IQVIA
10.4. Pharmaceutical Product Development
10.5. PAREXEL International
10.6. Syneos Health
10.7. ICON plc.
10.8. Medpace
10.9. CTI Clinical Trial and Consulting Services
10.10. QPS Neuropharmacology